These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31594214)

  • 21. Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.
    Barabas AZ; Lafreniere R
    Autoimmun Rev; 2005 Nov; 4(8):565-70. PubMed ID: 16214097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to polyclonal T-cell vaccination in patients with progressive multiple sclerosis.
    Seledtsova GV; Ivanova IP; Shishkov AA; Seledtsov VI
    J Immunotoxicol; 2016 Nov; 13(6):879-884. PubMed ID: 27602793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.
    Barabas AZ; Cole CD; Barabas AD; Cowan JM; Yoon CS; Waisman DM; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(4):201-12. PubMed ID: 15312125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rat kidney fraction 3 (rKF3) antigen and specific IgM antibody against rKF3 on the progression of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Barabas AN; Lafreniere R
    Pathol Int; 2006 Sep; 56(9):516-29. PubMed ID: 16930332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell-targeted CD40 DNA vaccine suppresses Th17 and ameliorates progression of experimental autoimmune glomerulonephritis.
    Li Q; Cao Q; Wang C; Nguyen H; Wang XM; Zheng G; Wang YM; Hu S; Alexander SI; Harris DCH; Wang Y
    J Leukoc Biol; 2019 Apr; 105(4):809-819. PubMed ID: 30811635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On natural and artificial vaccinations.
    Zinkernagel RM
    Annu Rev Immunol; 2003; 21():515-46. PubMed ID: 12500980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines to prevent and treat autoimmune diseases.
    Mor F; Cohen IR
    Int Arch Allergy Immunol; 1995 Dec; 108(4):345-9. PubMed ID: 7580306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of Heymann nephritis by a chemically modified renal antigen.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(5):277-85. PubMed ID: 15379960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of patients with autoimmune inflammatory rheumatic diseases.
    Westra J; Rondaan C; van Assen S; Bijl M
    Nat Rev Rheumatol; 2015 Mar; 11(3):135-45. PubMed ID: 25486980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the antigen (gp600) of Heymann nephritis.
    Makker SP; Singh AK
    Lab Invest; 1984 Mar; 50(3):287-93. PubMed ID: 6199583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of natural and immune IgM antibodies in immune responses.
    Boes M
    Mol Immunol; 2000 Dec; 37(18):1141-9. PubMed ID: 11451419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Modified Vaccination Technique.
    Barabas A; Cole C; Kovacs Z; Kovacs E; Lafreniere R
    Vaccines (Basel); 2018 Dec; 7(1):. PubMed ID: 30577575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of maternal antibodies on the infant immune response.
    Glezen WP
    Vaccine; 2003 Jul; 21(24):3389-92. PubMed ID: 12850346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines, adjuvants and autoimmunity.
    Guimarães LE; Baker B; Perricone C; Shoenfeld Y
    Pharmacol Res; 2015 Oct; 100():190-209. PubMed ID: 26275795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated antibody response by antigen presentation in immune complexes.
    Barabas AZ; Cole CD; Kovacs ZB; Lafreniere R
    Med Sci Monit; 2007 May; 13(5):BR119-24. PubMed ID: 17476190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyclonal hypergammaglobulinemia and autoantibody production induced by vaccination in farmed Atlantic salmon.
    Satoh M; Bjerkås I; Haugarvoll E; Chan EK; Szabo NJ; Jirillo E; Poppe TT; Sveier H; Tørud B; Koppang EO
    Fish Shellfish Immunol; 2011; 30(4-5):1080-6. PubMed ID: 21316456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.